Dentsply Sirona Inc (XRAY)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $1.83B
Last updated: Nov 17, 2026 at 11:06 AM ET
Dentsply Sirona Inc (XRAY) P/E Ratio & Valuation History
Dentsply Sirona (XRAY) trades at 6.6x trailing earnings and 0.5x sales. Its P/E of 6.6x is below its 5-year median of 13.5x. Its forward P/E is 7.1x. The median P/E across 9 similar companies is 28.0x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 7.0% lower over the next year. Its free cash flow yield is 5.8%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 6.6x |
| Forward P/E | 7.1x |
| Price to sales | 0.5x |
| Price to book | 1.3x |
| EV/EBITDA | 11.1x |
| Price to FCF | 17.3x |
| EV/FCF | 36.8x |
| PEG | 0.7 |
| FCF yield | 5.8% |
Historical Medians
Against its 10-year medians, its P/E is 64.7% below 18.7x, its P/S is 78.3% below 2.3x and its P/B is 35.0% below 2.0x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 6.6x | 13.5x | 18.7x |
| P/S | 0.5x | 1.5x | 2.3x |
| P/B | 1.3x | 1.8x | 2.0x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 7.2x in 2025 to 29.3x in 2020. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $11.43 | 7.2x | 0.6x | 1.7x |
| 2024 | $18.98 | 11.4x | 1.0x | 2.0x |
| 2023 | $35.59 | 19.4x | 1.9x | 2.3x |
| 2022 | $31.84 | 15.3x | 1.7x | 1.8x |
| 2021 | $55.79 | 19.4x | 2.9x | 2.4x |
| 2020 | $52.36 | 29.3x | 3.4x | 2.3x |
| 2019 | $56.59 | 23.1x | 3.1x | 2.5x |
| 2018 | $37.21 | 18.5x | 2.1x | 1.6x |
| 2017 | $65.83 | 24.7x | 3.8x | 2.3x |
| 2016 | $57.73 | 20.8x | 3.4x | 1.7x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About XRAY
What is XRAY's forward P/E ratio?
Dentsply Sirona has a forward P/E ratio of 7.1x.
Is XRAY stock overvalued?
GNG's valuation label for XRAY is Undervalued. Its P/E of 6.6x compares with a median of 28.0x across 9 similar companies.
What is XRAY's price to sales ratio?
Dentsply Sirona has a price to sales ratio of 0.5x.
What is Dentsply Sirona's average P/E ratio over 5 years?
Dentsply Sirona's median P/E over the last 5 years is 13.5x, from 60 month-end values through Oct 2026.
What is XRAY's PEG ratio?
Dentsply Sirona has a PEG ratio of 0.7.
XRAY pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts